AIIMS Delhi to hold 2nd session of National CGR on COVID-19 issues today

Published On 2020-07-30 04:15 GMT   |   Update On 2020-07-30 04:15 GMT

New Delhi - All India Institute of Medical Sciences (AIIMS), Delhi will hold the second session of National Clinical Grand Rounds (CGR) at 3 PM today. The interactive session, which will be led by AIIMS Director, Dr. Randeep Guleria, is aimed at facilitating insightful discussion on COVID related issues. Senior doctors of the premier health Institute will be discussing on the usage of...

Login or Register to read the full article

New Delhi - All India Institute of Medical Sciences (AIIMS), Delhi will hold the second session of National Clinical Grand Rounds (CGR) at 3 PM today. The interactive session, which will be led by AIIMS Director, Dr. Randeep Guleria, is aimed at facilitating insightful discussion on COVID related issues.

Senior doctors of the premier health Institute will be discussing on the usage of antiviral and anti-IL6 drugs in moderately severe COVID cases.

Read Also: AIIMS 'e-ICU' video COVID 19 consultation program gains traction

Doctors from medical colleges and Senior Physicians from hospitals located across the country and abroad will be participating in the online session. In an effort to share its experience and initiate discussions on management of common issues related to COVID-19, AIIMS Delhi with NITI Aayog and Union Health Ministry launched the National Clinical Grand Rounds (CGR) on COVID-19.

These sessions include presentation of clinical cases by physicians directly involved in COVID management. Challenges faced in the management are also discussed by a panel of eminent experts from across the country and outside India.

Read Also: AIIMS begins India's first COVID-19 vaccine trial

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News